New Cell Titles Further ScienceDirect Offering
Specialists in microbiology and stem cell biology to benefit from new content on the world's largest professional research database
Amsterdam, March 14, 2007 – This year, Elsevier, a leading publisher of scientific, technical and medical (STM) information, is adding two new, groundbreaking Cell Press titles - Cell Host & Microbe and Cell Stem Cell – to its platform, ScienceDirect. To celebrate the launch, access to the first three issues of both journals is complimentary for three months.
A requisite addition to the Cell Press collection on ScienceDirect, which includes leading titles Cell and Neuron, Cell Host & Microbe and Cell Stem Cell will be valuable resources for specialists in microbiology and stem cell biology.
Cell Host & Microbe - available on ScienceDirect from March 14, 2007 - will provide a forum for the exchange of ideas and concepts between scientists studying the microbe with those studying the host immune and cellular response upon colonization or infection by a microbe. The journal will publish findings related to microbes, from molecular and cellular biology to translational studies, with particular emphasis on the interface between the microbe and its host. The unifying theme will be the integrated study of microbes in conjunction and communication with each other, their host and the cellular environment they live in.
Cell Stem Cell - available on ScienceDirect from June 6, 2007 - will cover the entire spectrum of stem cell biology. The journal’s goal will be to provide a forum for the publication of leading stem cell research and the exchange of ideas between scientists working in the burgeoning field of stem cell biology. Cell Stem Cell will be the official affiliated journal of the International Society for Stem Cell Research (ISSCR).
"Continuing to build on the extensive collection of high-quality content already available on ScienceDirect is one of our highest priorities," said Joep Verheggen, Director of ScienceDirect. "I am particularly pleased with the forthcoming inclusion of Cell Host & Microbe and Cell Stem Cell because they meet the immediate needs of scientists working in the growing fields of microbiology and stem cell biology: not only will these titles cover important new developments, they will also help inspire new findings by enabling scientists to work together and share ideas."
About Cell Press
Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting biology research and reviews. Cell Press journals include the flagship journal Cell , Neuron , Immunity , Molecular Cell , Developmental Cell , Cancer Cell , Current Biology , Structure , Chemistry & Biology , Cell Metabolism , and two new titles launching in 2007, Cell Host & Microbe and Cell Stem Cell. Cell Press’s mission is to continue to publish and develop journals that deliver the highest possible intellectual rigor, promote community trust, and are widely disseminated.
Over a quarter of the world's full text scientific, technical and medical (STM) articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect.
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over eight million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2,000 journals published by Elsevier and dynamic linking to journals from approximately 350 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and e-Books in all fields of science seamlessly interlinks with primary research referenced in journal articles.
About the ISSCR
The International Society for Stem Cell Research is an independent, non-profit organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Head of Marketing
+31 (0) 20 485 2893